BGI Group Included in First Fortune China ESG List

SHENZHEN, China, Aug. 23, 2022 /PRNewswire/ — BGI Group is featured among the top companies in China in Fortune China’s inaugural China ESG list, published this week.

As Fortune China notes in their introduction to the list of 40 featured companies, they were delighted to find that although ESG is a foreign concept, there have been many active practitioners across various industries in China.

Fortune China highlighted four achievements by BGI Group for inclusion on the list:

BGI Group’s work during the COVID crisis, particularly in constructing Huo-Yan Laboratories in China and globally. The health screening services BGI Group provides to people in rural and impoverished areas, with more than 13 million health screenings provided. BGI Group’s work to prevent and manage hemoglobinopathies such as thalassemia and sickle cell disease. The social responsibility activities BGI Group undertakes in providing public awareness health campaigns.

“While we are honored to receive this recognition of our ESG work, BGI Group has always been focused on the development of life sciences for the betterment of mankind,” said a BGI Group spokesperson. “Everything we do should be focused on improving lives, which is why our work includes ground-breaking science discoveries, innovative research into microbiology and biodiversity, diagnostic testing services to trace viruses and diseases, and the development of next generation technologies for large-scale gene sequencing.”

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.